Adage Capital Partners Gp, L.L.C. Pro Qr Therapeutics N.V. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 8,102,098 shares of PRQR stock, worth $14.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,102,098
Previous 9,602,280
15.62%
Holding current value
$14.4 Million
Previous $26.2 Million
58.9%
% of portfolio
0.02%
Previous 0.05%
Shares
13 transactions
Others Institutions Holding PRQR
# of Institutions
69Shares Held
42.1MCall Options Held
30.1KPut Options Held
5.3K-
Privium Fund Management B.V.4.99MShares$8.87 Million1.74% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.28MShares$5.85 Million0.49% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.07MShares$3.69 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.05MShares$3.66 Million1.03% of portfolio
-
Abrdn PLC1.85MShares$3.29 Million0.0% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $127M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...